This METTLER TOLEDO white paper explores digital transformation in regulated pharma and biopharma laboratories. It argues digitalization is essential for compliance, efficiency, and knowledge management, moving beyond “paper on glass” to fully integrated workflows. Regulatory bodies like the FDA and EU now expect technical controls, data integrity, and automation, pushing labs to replace manual processes. Benefits include faster product release, reduced compliance costs, and improved data accuracy. Case studies show that implementing LabX instrument control software enhances audit trails, reduces transcription errors, and improves detection of quality issues, ultimately strengthening compliance and accelerating time-to-market.

Join for free to read